文献速递产科母胎医学

新型子宫收缩监测实现远程自测非应激试验

Novel uterine contraction monitoring to enable remote, self-administered nonstress testing.
PubMed 文献 · Am J Obstet Gynecol · 2021-11-08

这项前瞻性、开放标签、两中心研究在118名≥32 0/7周单胎妊娠第一产程孕妇中验证无线妊娠监测仪检测子宫收缩的算法。验证阶段,无线监测仪阳性一致率为84.8%(2722/3210),假阳性率为24.8%(897/3619);在三种设备同时监测的亚组中,无线监测仪阳性一致率显著优于宫缩外监护(P<.0001),但假阳性率显著更高(P<.0001)。无线监测仪阳性一致率在不同体重指数组间无差异,而宫缩外监护在肥胖组较正常体重组显著降低(P=.024)。

要点

  • 无线妊娠监测仪检测子宫收缩的阳性一致率为84.8%,假阳性率为24.8%。
  • 三种设备同时监测亚组中,无线监测仪阳性一致率显著优于宫缩外监护(P<.0001),假阳性率显著更高(P<.0001)。
  • 宫缩外监护阳性一致率在肥胖组较正常体重组显著降低(P=.024),无线监测仪则不受体重指数影响。

核心结论

  • 这种通过为家庭自用设计的无线妊娠监测设备无创监测子宫活动的新方法,比常用的宫缩外监护更准确,且不受体重指数影响。
  • 结合先前报道的远程胎心率监测能力,新增的子宫收缩检测能力构成了远程实施非应激试验的完整远程医疗解决方案。

研究设计与样本

  • 前瞻性、开放标签、两中心研究,评估无线妊娠监测仪与宫内压力导管同时检测子宫收缩(ClinicalTrials.gov标识符:NCT03889405)。
  • 纳入≥32 0/7周妊娠、处于第一产程的单胎妊娠孕妇,研究包括训练阶段和验证阶段。
  • 每台设备同时被动记录30至60分钟;验证阶段部分监测会话中同时部署宫缩外监护。
  • 三位母胎医学专家在不知数据来源的情况下识别并标记所有模态中的收缩。
  • 共纳入118名参与者,训练阶段40名,验证阶段78名(其中78名中39名同时由全部3种设备监测),平均孕龄38.6周。

主要发现

  • 训练阶段,无线监测仪阳性一致率为88.4%(1440/1692次收缩),假阳性率为15.3%(260/1700)。
  • 验证阶段,使用 refined 并最终确定的算法,无线妊娠监测仪阳性一致率为84.8%(2722/3210),假阳性率为24.8%(897/3619)。
  • 仅用无线监测仪和宫内压力导管监测的亚组,阳性一致率为89.0%(1191/1338),假阳性率相似为25.4%(406/1597)。
  • 全部3种设备监测的亚组中,无线监测仪阳性一致率显著优于宫缩外监护(P<.0001),而假阳性率显著更高(P<.0001)。
  • 宫缩外监护阳性一致率在肥胖组较正常体重组显著降低(P=.024),而无线监测仪阳性一致率在不同体重指数组间无差异。

关键数值与推荐

  • 训练阶段无线监测仪阳性一致率88.4%(1440/1692),假阳性率15.3%(260/1700)。
  • 验证阶段无线妊娠监测仪阳性一致率84.8%(2722/3210),假阳性率24.8%(897/3619)。
  • 仅无线监测仪和宫内压力导管亚组阳性一致率89.0%(1191/1338),假阳性率25.4%(406/1597)。
  • 全部3种设备亚组中,无线监测仪阳性一致率显著优于宫缩外监护(P<.0001),假阳性率显著更高(P<.0001)。
  • 宫缩外监护阳性一致率在肥胖组较正常体重组显著降低(P=.024)。

临床怎么用

  • 作者认为,该无线妊娠监测设备设计用于家庭自测,可无创监测子宫活动,比常用宫缩外监护更准确且不受体重指数影响。
  • 作者认为,结合远程胎心率监测能力,该设备构成了远程实施非应激试验的完整远程医疗解决方案。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The serial fetal monitoring recommended for women with high-risk pregnancies places a substantial burden on the patient, often disproportionately affecting underprivileged and rural populations. A telehealth solution that can empower pregnant women to obtain recommended fetal surveillance from the comfort of their own home has the potential to promote health equity and improve outcomes. We have previously validated a novel, wireless pregnancy monitor that can remotely capture fetal and maternal heart rates. However, such a device must also detect uterine contractions if it is to be used to robustly conduct remote nonstress tests. OBJECTIVE: This study aimed to describe and validate a novel algorithm that uses biopotential and acoustic signals to noninvasively detect uterine contractions via a wireless pregnancy monitor. STUDY DESIGN: A prospective, open-label, 2-center study evaluated simultaneous detection of uterine contractions by the wireless pregnancy monitor and an intrauterine pressure catheter in women carrying singleton pregnancies at ≥32 0/7 weeks' gestation who were in the first stage of labor (ClinicalTrials.gov Identifier: NCT03889405). The study consisted of a training phase and a validation phase. Simultaneous recordings from each device were passively acquired for 30 to 60 minutes. In a subset of the monitoring sessions in the validation phase, tocodynamometry was also deployed. Three maternal-fetal medicine specialists, blinded to the data source, identified and marked contractions in all modalities. The positive agreement and false-positive rates of both the wireless monitor and tocodynamometry were calculated and compared with that of the intrauterine pressure catheter. RESULTS: A total of 118 participants were included, 40 in the training phase and 78 in the validation phase (of which 39 of 78 participants were monitored simultaneously by all 3 devices) at a mean gestational age of 38.6 weeks. In the training phase, the positive agreement for the wireless monitor was 88.4% (1440 of 1692 contractions), with a false-positive rate of 15.3% (260/1700). In the validation phase, using the refined and finalized algorithm, the positive agreement for the wireless pregnancy monitor was 84.8% (2722/3210), with a false-positive rate of 24.8% (897/3619). For the subgroup who were monitored only with the wireless monitor and intrauterine pressure catheter, the positive agreement was 89.0% (1191/1338), with a similar false-positive rate of 25.4% (406/1597). For the subgroup monitored by all 3 devices, the positive agreement for the wireless monitor was significantly better than for tocodynamometry (P<.0001), whereas the false-positive rate was significantly higher (P<.0001). Unlike tocodynamometry, whose positive agreement was significantly reduced in the group with obesity compared with the group with normal weight (P=.024), the positive agreement of the wireless monitor did not vary across the body mass index groups. CONCLUSION: This novel method to noninvasively monitor uterine activity, via a wireless pregnancy monitoring device designed for self-administration at home, was more accurate than the commonly used tocodynamometry and unaffected by body mass index. Together with the previously reported remote fetal heart rate monitoring capabilities, this added ability to detect uterine contractions has created a complete telehealth solution for remote administration of nonstress tests.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Schwartz N, Mhajna M, Moody HL, et al. Novel uterine contraction monitoring to enable remote, self-administered nonstress testing. Am J Obstet Gynecol. 2021. PMID: 34762863. doi:10.1016/j.ajog.2021.11.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。